Acute Diverticulitis
Acute diverticulitis is an inflammation or infection of small pouches that can form in the walls of the digestive tract, leading to symptoms such as abdominal pain, fever, and changes in bowel habits.
Recurrent Diverticulitis: MBK-01 Capsules
We are studying whether MBK-01, a new intestinal microbiota capsule, can help reduce episodes of recurrent diverticulitis. The trial will also assess its safety and find the best dosage for patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 70 years old?
- Have you had three or more episodes of diverticulitis in the last 3 years?
- Have you had any episodes of diverticulitis in the last 30 days?
- Are you currently pregnant or breastfeeding?
- Have you taken any antibiotics in the last 30 days?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Fecal Microbiota
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitario Ramon Y Cajal
Jiménez
Colmenar Viejo, Spain
Sponsor: Mikrobiomik Healthcare Company S.L.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.